newsfilter
← Latest News
Earnings Call Transcripts·

Portola Pharmaceuticals' (PTLA) CEO Bill Lis on CRL from FDA for BLA for AndexXa (Transcript)

Portola Pharmaceuticals' (PTLA) CEO Bill Lis on CRL from FDA for BLA for AndexXa (Transcript)